These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 12042076

  • 1. Adherence to HAART among patients with HIV: breakthroughs and barriers.
    Ickovics JR, Meade CS.
    AIDS Care; 2002 Jun; 14(3):309-18. PubMed ID: 12042076
    [Abstract] [Full Text] [Related]

  • 2. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K.
    Verh K Acad Geneeskd Belg; 2001 Jun; 63(5):447-73. PubMed ID: 11813503
    [Abstract] [Full Text] [Related]

  • 3. Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver.
    Kerr T, Palepu A, Barness G, Walsh J, Hogg R, Montaner J, Tyndall M, Wood E.
    Antivir Ther; 2004 Jun; 9(3):407-14. PubMed ID: 15259903
    [Abstract] [Full Text] [Related]

  • 4. Utility of the Millon Behavioral Medicine Diagnostic (MBMD) to predict adherence to highly active antiretroviral therapy (HAART) medication regimens among HIV-positive men and women.
    Cruess DG, Minor S, Antoni MH, Millon T.
    J Pers Assess; 2007 Dec; 89(3):277-90. PubMed ID: 18001228
    [Abstract] [Full Text] [Related]

  • 5. Greater adherence to highly active antiretroviral therapy (HAART) between pregnant versus non-pregnant women living with HIV.
    Zorrilla CD, Santiago LE, Knubson D, Liberatore K, Estronza G, Colón O, Acevedo M.
    Cell Mol Biol (Noisy-le-grand); 2003 Dec; 49(8):1187-92. PubMed ID: 14983985
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
    Palepu A, Tyndall MW, Chan K, Wood E, Montaner JS, Hogg RS.
    Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The impact of incarceration upon adherence to HIV treatment among HIV-positive injection drug users: a qualitative study.
    Small W, Wood E, Betteridge G, Montaner J, Kerr T.
    AIDS Care; 2009 Jun; 21(6):708-14. PubMed ID: 19806487
    [Abstract] [Full Text] [Related]

  • 15. Take HAART: medication adherence in the era of highly active antiretroviral therapy.
    Allardice K.
    Aust Nurs J; 2002 Apr; 9(9):19-21. PubMed ID: 12017049
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. One-year adherence to clinic visits after highly active antiretroviral therapy: a predictor of clinical progress in HIV patients.
    Park WB, Choe PG, Kim SH, Jo JH, Bang JH, Kim HB, Kim NJ, Oh M, Choe KW.
    J Intern Med; 2007 Mar; 261(3):268-75. PubMed ID: 17305649
    [Abstract] [Full Text] [Related]

  • 18. Standard care impact on effects of highly active antiretroviral therapy adherence interventions: A meta-analysis of randomized controlled trials.
    de Bruin M, Viechtbauer W, Schaalma HP, Kok G, Abraham C, Hospers HJ.
    Arch Intern Med; 2010 Feb 08; 170(3):240-50. PubMed ID: 20142568
    [Abstract] [Full Text] [Related]

  • 19. Adherence to highly active antiretroviral therapy predicts virologic outcome at an inner-city human immunodeficiency virus clinic.
    McNabb J, Ross JW, Abriola K, Turley C, Nightingale CH, Nicolau DP.
    Clin Infect Dis; 2001 Sep 01; 33(5):700-5. PubMed ID: 11486292
    [Abstract] [Full Text] [Related]

  • 20. Adherence in clinical trials and in clinical practice.
    Walsh JC.
    Antivir Ther; 1999 Sep 01; 4 Suppl 3():49-54. PubMed ID: 16021871
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.